Navigation Links
Minimally Invasive Devices, Inc. Awarded CE Mark for FloShield™
Date:7/20/2011

COLUMBUS, Ohio, July 20, 2011 /PRNewswire/ -- Minimally Invasive Devices, Inc., (MID) has been awarded CE Mark Certification for its FloShield™ laparoscopic visualization system.  This certification is mandatory for sale of certain medical devices in the European Union.  

The FloShield system provides for an uninterrupted clear view during laparoscopic procedures.  FloShield uses airflow from the insufflator to defog and deflect debris from the lens of the laparoscope without removing the scope from the abdominal cavity for cleaning.  Surgeons have to interrupt surgery as often as ten times per hour to remove the scope and manually clean it.  FloShield dramatically reduces, and often eliminates, interruptions to clean the lens. FloShield is the only medical device that prevents optics from becoming obscured.

"The advent of HD ten years ago was the last breakthrough in laparoscopic vision," says Wayne Poll, M.D, FloShield inventor and CEO of MID.  "FloShield represents the last hurdle in laparoscopic visualization."

The FloShield system, which received FDA 510(k) approval in 2008, is in early distribution within the U.S., and in use at approximately 40 hospitals throughout the country.   The system was certified ISO 13485 compliant in December of 2010, clearing the path for CE Marking.  

"We have been contacted by several European and Asian distributors who are interested in FloShield," says Poll.

FloShield is manufactured in Franklin, OH.  Poll says the company has more than tripled employment over the last two years from four full time employees to 14.

About Minimally Invasive Devices, Inc.

Minimally Invasive Devices, Inc. (MID) was founded in 2007, by Wayne Poll, M.D., a laparoscopic surgeon.  MID's first market offering is the FloShield™ system of laparoscopic visualization devices.  The FloShield franchise will soon add Flo-X™, the first biocompatible agent with 510(k) clearance for washing the lens of the laparoscope in situ.  The company is also developing complimentary technology that manages the entire air space in laparoscopic surgery, which will improve the environment and experience for laparoscopic surgeons.  

Funding for the company was led by the Ohio TechAngel Funds with additional funding from three other Ohio-based angel funds including Queen City, NorthCoast and ECOTAF.  MID has received venture funding from Charter Life Sciences and Reservoir Partners.  The company is headquartered at 1275 Kinnear Rd., Columbus, OH in the TechColumbus technology business incubator.   For more information, visit www.midsurgical.com


'/>"/>
SOURCE Minimally Invasive Devices, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results
2. New Minimally Invasive Breast Reconstructive Procedure for Breast Cancer Patients - Actively Recruiting Participants for Clinical Study
3. Minimally Invasive Treatment Reduces Shoulder Pain From Tendonitis
4. Positive Results Published Using AtriCure Minimally Invasive Products
5. Edwards Lifesciences Announces First Implants in U.S. Study of Minimally-Invasive Pulmonic Valve
6. New Minimally Invasive Surgical Procedure Restores Quality of Life in Patients With Potentially Debilitating Spinal Condition
7. New Study Offers More Than a Decade of Evidence for Minimally-Invasive Surgery to Treat Female Incontinence
8. Wrist Access Safer, Easier for Many Patients Undergoing Minimally Invasive Treatment of Blocked Heart Arteries
9. IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile
10. Gallbladder Removal Through Vagina Offers Minimally Invasive Alternative
11. Cardiogenesis Announces Presentation of its PHOENIX(R) Combination TMR Plus Stem Cell Delivery System at the International Society of Minimally Invasive Cardiothoracic Surgeons (ISMICS) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... Dublin ... of the " Global Markets for Spectroscopy Equipment" ... This report focuses on the global ... including its applications in various applications. The report deals ... three main industries: pharmaceutical and biotechnology, food and beverage, ...
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
Breaking Medicine Technology:
(Date:6/27/2016)... California (PRWEB) , ... June 27, 2016 , ... "FCPX ... fully customizable inside of Final Cut Pro X," said Christina Austin - CEO of ... unique style. Final Cut Pro X users can now reveal the media ...
(Date:6/27/2016)... Park, KS (PRWEB) , ... June 27, 2016 , ... ... in retailers of Eyeglasses . , Millions of individuals in the United States ... eyeglasses have become a way to both correct vision and make a fashion statement. ...
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
Breaking Medicine News(10 mins):